Patents by Inventor Frederic Sallman

Frederic Sallman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Natural ligand of G protein coupled receptor RCC356 and uses thereof
    Patent number: 8008023
    Abstract: The invention relates to the identification of isovaleric acid as a natural ligand of the RCC356 G-protein coupled receptor (GPCR). The invention encompasses the use of the interaction of RCC356 polypeptides and isovaleric acid as the basis of screening assays for agents that modulate the activity of the RCC356 receptor. The invention also encompasses diagnostic and other assays performed based upon the RCC356/isovaleric acid interaction, as well as kits for performing diagnostic and screening assays.
    Type: Grant
    Filed: May 12, 2008
    Date of Patent: August 30, 2011
    Assignee: Chemcom S.A.
    Inventors: Frédéric Sallman, Alex Veithen, Magali Philippeau
  • Natural ligand of G protein coupled receptor RCC356 and uses thereof
    Publication number: 20090264526
    Abstract: The invention relates to the identification of isovaleric acid as a natural ligand of the RCC356 G-protein coupled receptor (GPCR). The invention encompasses the use of the interaction of RCC356 polypeptides and isovaleric acid as the basis of screening assays for agents that modulate the activity of the RCC356 receptor. The invention also encompasses diagnostic and other assays performed based upon the RCC356/isovaleric acid interaction, as well as kits for performing diagnostic and screening assays.
    Type: Application
    Filed: May 12, 2008
    Publication date: October 22, 2009
    Applicant: Chemcom S. A.
    Inventors: Frederic Sallman, Alex Veithen, Magali Philippeau
  • Novel in vitro methods for studying receptors recognizing volatile compounds
    Publication number: 20090136968
    Abstract: The present invention in particular relates to in vitro methods to identify and/or confirm the binding and/or function of a volatile compound onto a membrane-integrated receptor using volatile-compound-Binding Protein (BP) or compositions thereof. Additionally, the present invention relates to kits comprising receptor proteins recognizing volatile compounds or a candidate receptor for said compound; and; BP, a complex or composition thereof. Said kits may be used to identify and/or confirm the binding and/or function of volatile compounds onto a membrane-integrated receptor.
    Type: Application
    Filed: May 12, 2008
    Publication date: May 28, 2009
    Applicant: Chemcom S. A.
    Inventor: Frederic Sallman